¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"somatic mutation theory of cancer"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
¿µ¹® mutation ÇÑ±Û µ¹¿¬º¯ÀÌ
¼³¸í   
  ¼¼Æ÷ÀÇ dna ÀÚüÀÇ º¯ÀÌ¿¡ ÀÇÇØ ÀϾ´Â ¼¼Æ÷º¯À̸¦ ¸»ÇÑ´Ù. ÀÌ·¯ÇÑ °æ¿ì µ¹¿¬º¯À̷ΠÀϾ ¼¼Æ÷´Â ±× ÀÌÈÄ µþ¼¼Æ÷(daughter cell)¿¡¼­µµ ±× º¯À̰¡ ¿©ÀüÈ÷ À¯ÁöµÇ¹Ç·Î Á¾(species)ÀÇ º¯È­³ª, È¤Àº ¼¼Æ÷ÀÇ ¾Ç¼ºº¯È¯(malignant transformation)¿¡ °ü¿©ÇÑ´Ù.
¿µ¹® ovarian cancer ÇÑ±Û ³­¼Ò¾Ï
¼³¸í   
  ¿©¼ºÀÇ ³­¼Ò¿¡ ¹ß»ýÇϴ ¾Ï. ºÎÀΰúÁ¾¾çÀ¸·Î¼­ 50¼¼ À̻󠿩¼º¾Ç¼ºÁ¾¾çÀÇ ¾à 18%¸¦ Â÷ÁöÇÑ´Ù. Á¾¾çÀº ´ë°³ º¹ºÎ ±í¼÷È÷ À§Ä¡ÇϹǷΠÁ¾¾çÀÌ ¸¹ÀÌ ÁøÇàµÈ »óÅ¿¡¼­ ¹ß°ßµÇ´Â ¼ö°¡ ¸¹À¸¸ç, ¶ÇÇÑ Á¾¾çÀÇ Ãʱ⿡´Â Áõ»óÀÌ °ÅÀÇ ¾ø´Â °æ¿ì°¡ ¸¹¾Æ ´õ¿í Á¶±â¹ß°ßÀÌ ¾î·Æ´Ù.
  
  ¾ÆÁÖ ´Ù¾çÇÑ Á¾·ùÀÇ ¾ÏÀÌ ¹ß»ýÇϸç, ¿¹Èĵµ °¢±â ±× Á¾¾çÀÇ Á¾·ù¿¡ µû¶ó ´Ù¸£´Ù. ´ëÇ¥ÀûÀΠ¾ÏÀ¸·Î À强³¶»ù¾ÏÁ¾(serous cystadenocarcinoma), Á¡¾×³¶»ù¾ÏÁ¾(mucinous cystadenocarcinoma), Á¾ÀÚ¼¼Æ÷Á¾(germinoma µîÀÌ ÀÖ´Ù. Ä¡·á´Â ¼ö¼úÀû Ä¡·á°¡ ¼±ÇàµÇ¾î¾ß ÇÏÁö¸¸, ¸¹ÀÌ ÁøÇàµÇ¾î À̹̠´Ù¸¥ Á¶Á÷À¸·Î ÀüÀ̰¡ ÀÌ·ç¾îÁø »óÅ¿¡¼­´Â È­Çпä¹ýÀÌ ¼±ÅÃÀûÀ¸·Î »ç¿ëµÈ´Ù.
¿µ¹® cancer ÇÑ±Û ¾Ï
¼³¸í   
  ³¡¾øÀÌ ºÐ¿­À» ÇÏ¿© Ç÷¾×À̳ª ¸²ÇÁ°üÀ» ÅëÇÏ¿© ´Ù¸¥ Àå±â¿¡±îÁö ÀüÆÄµÉ ¼ö Àִ ¼¼Æ÷ÀÇ µ¢¾î¸®. ÁǼº ½Å»ý¹°À» ¸»ÇÑ´Ù. ½Å»ý¹°Àº ¾Ç¼º°ú ¾ç¼ºÀÌ Àִµ¥, ¾Ç¼ºÀÏ °æ¿ì¿¡´Â ¼ºÀåÀÌ ¸Å¿ì ºü¸£°í Ç÷¾×À̳ª ¸²ÇÁ°üÀ» ÅëÇØ¼­ ¸Ö¸® ´Ù¸¥ ¶³¾îÁø Àå±â·Î ¾Ï¼¼Æ÷ÀÇ ÀüÆÄ°¡ °¡´ÉÇÏ¿© ´Ù¸¥ Àå±â¿¡µµ ¾ÏÀ» ÀüÀÌÇϸç, ¾ç¼ºÀº ÃµÃµÈ÷ ÀÚ¶ó°í ´Ù¸¥°÷À¸·Î ÀüÀ̰¡ »ý±âÁö ¾Ê´Â´Ù.
  
  ¾ÏÀº ¾ÏÁ¾°ú À°Á¾ÀÇ µÎ °¡Áö·Î ³ª´­ ¼ö°¡ ÀÖ´Ù. ¾ÏÁ¾À̶õ »óÇǼ¼Æ÷ÀÇ °úµµÇÑ Áõ½Ä¿¡ ÀÇÇÑ ¾Ç¼º½Å»ý¹°À» À̸£´Â ¸»À̰í À°Á¾À̶õ ºñ»óÇǼº¼¼Æ÷ Æ¯È÷ Áß°£¿±¼¼Æ÷(¹ß»ý´ç½Ã¿¡ Áß°£¿±¿¡ ÇØ´çÇϴ Á¶Á÷À¸·Î ¹ß»ýÈÄ¿¡ Á¶Á÷»çÀÌ¿¡ ºÐÆ÷Çϸ鼭 Á¶Á÷À» ÁöÁöÇϴ ¿ªÇÒÀ» Çϴ °áÇÕÁ¶Á÷, Ç÷°ü, ¸²ÇÁ°ü µîÀÌ µÈ´Ù)ÀÇ °úµµÇÑ Áõ½Ä¿¡ ÀÇÇÑ ¾Ç¼º ½Å»ý¹°À» À̸£´Â ¸»ÀÌ´Ù.
¿µ¹® cancer surgery ÇÑ±Û ¾Ï ¼ö¼ú
¼³¸í   
  ¾ÏÀÇ 4´ë Ä¡·á¹ýÀº ¿Ü°úÀû ¼ö¼ú¿ä¹ý, ¹æ»ç¼± Ä¡·á¹ý, Ç׾ϠȭÇпä¹ý, ¸é¿ª¿ä¹ý µîÀ» ¸»Çϸç ÀÌÁß ¼ö¼ú¿ä¹ý°ú ¹æ»ç¼± ¿ä¹ýÀº ±¹¼ÒÀû ¿ä¹ýÀ¸·Î¼­ ¾Ï¼¼Æ÷°¡ ¿ø¹ßÀå±â(óÀ½ ¾ÏÀÌ ¹ß»ýÇÑ Àå±â)³ª ±¹¼Ò ¸²ÇÁÀý±îÁö ±¹ÇѵǾî Àִ Á¦ 1, 2±â ¾ÏÀÇ Ä¡·á¿¡ »ç¿ëµÈ´Ù. È­Çпä¹ý°ú ¸é¿ª¿ä¹ýÀº Àü½Å¿ä¹ýÀ¸·Î¼­ Á¦ 3, 4±â ¾Ï¿¡ ÁַΠ»ç¿ëµÇ¸ç, 1, 2±â ¾ÏÀÇ Ä¡·á ÈÄ ´«¿¡ º¸ÀÌÁö ¾Ê°Ô ³²¾Æ ÀÖÀ» ¼ö Àִ ÀÜ·ù¾Ï¼¼Æ÷³ª ¹Ì¼¼ÀüÀÌ ¾Ï¼¼Æ÷ÀÇ ¿ÏÀüÆÄ±«, »ç¸êÀ» À§ÇØ »ç¿ëµÈ´Ù. ¹éÇ÷º´, ¸²ÇÁÁ¾°ú °°ÀÌ È­Çпä¹ýÁ¦¿¡ Àß µè´Â Ç÷¾×¾Ï, ¸²ÇÁÁ¾°ú °íȯÁ¾°ú °°ÀÌ ¹æ»ç¼± Ä¡·á¿¡ Àß µè´Â ¾ÏÀ» Á¦¿ÜÇÑ ´ëºÎºÐÀÇ °íÇü¾Ï(solid tumor)ÀΠÀ§Ã¢ÀÚ°ü¾Ï, °£¾Ï, ÀÌÀÚ¾Ï, À¯¹æ¾Ï, °©»ó»ù¾Ï, Æó¾Ï, Èæ»öÁ¾, ¿¬Á¶Á÷¾Ï, »ÀÀ°Á¾, Ä§»ù¾Ï µîÀº ¸ðµÎ ¼ö¼ú¿ä¹ýÀ¸·Î Ä¡·áÇÏ¿©¾ß ÇÑ´Ù.
  
  ¾Ï¼ö¼úÀÇ ±âº»¿øÄ¢: ¾Ï¼ö¼úÀÇ 3°¡Áö ±âº»¿ä°ÇÀº ¾ÈÀü¼º, ±ÙÄ¡¼º, ±â´Éº¸Á¸¼ºÀ̸砾ϼö¼ú½Ã¿¡´Â ¾Ïº´Å͸¦ µÇµµ·Ï Á¶½ÉÇØ¼­ Àû°Ô ¸¸Áö¸é¼­ ¼ö¼úÇÏ°í ¾Ïº´Å͸¦ °ø±ÞÇϴ µ¿Á¤¸Æ°ú ¸²ÇÁ°üÀ» ¸ÕÀú °áÂûÇÏ¿© ¾Ïº´ÅͰ¡ ÆÛÁö´Â °ÍÀ» ¹æÁöÇÑ´Ù.
  
  ¾Ï¼ö¼úÀÇ ¸ñÇ¥´Â ±ÙÄ¡Àû ÀýÁ¦¼ö¼ú(radical surgery)ÀÌ´Ù. ±×·¯³ª À̰ÍÀÌ ºÒ°¡´ÉÇѠȯÀÚ¿¡¼­´Â ÃâÇ÷, Æó»ö, Ãµ°ø µîÀÇ ÇÕº´ÁõÀÌ ¹ß»ýÇßÀ»¶§ ±¸±Þ¸ñÀûÀ¸·Î È¤Àº Áö¼ÓÀû µ¿ÅëÀÌ ÀÖÀ»¶§ »ýȰ³»¿ëÀÇ ÁúÀû °³¼±À» À§ÇÏ¿© °í½ÄÀû ¼ö¼ú(palliative surgery)À» ÇÑ´Ù. ±×¸®°í ¾ÏÀÇ Á¤È®ÇÑ Áø´Ü°ú ÁøÇ൵ÀÇ °áÁ¤À» À§ÇÑ Áø´ÜÀû ¼ö¼ú(diagnostic surgery)ÀÌ ÀÖ´Ù.
¿µ¹® breast cancer ÇÑ±Û À¯¹æ¾Ï
¼³¸í   
  À¯¹æÀº Áö¹æÁ¶Á÷°ú º»·¡ÀÇ ¸ñÀûÀΠÁ£À» »ý»êÇϴ »ùÁ¶Á÷, ±×¸®°í ÀÌ »ùÁ¶Á÷¿¡¼­ »ý»êÇÑ Á£À» ¹Û¿¡±îÁö ³»º¸³»´Â °üÁ¶Á÷, ±×¸®°í ÀÌ »ùÁ¶Á÷°ú °üÁ¶Á÷ÀÇ ÁÖÀ§¸¦ µÑ·¯½Î°í ÀÖÀ¸¸é¼­ À̰͵éÀÇ ¸ð¾çÀ» À¯ÁöÇØÁִ °£Áú·Î ÀÌ·ç¾îÁø´Ù. À¯¹æ¾ÏÀ̶õ »ùÁ¶Á÷°ú °üÁ¶Á÷¿¡¼­ ±â¿øÇϴ Á¾¾çÀ» ¸»ÇÑ´Ù.
  
  À¯¹æ¾ÏÀ» ¹ß»ý½Ãų ¼ö Àִ À§ÇèÀÎÀڴ ¿©·¯ °¡Áö°¡ ¹àÇôÁ® ÀÖ´Ù. ±×Áß¿¡¼­ ´ëÇ¥ÀûÀΠ°ÍÀº ´ÙÀ½°ú °°´Ù.
  
  1.À¯ÀüÀû ¿äÀΣ­°¡Á· Áß¿¡¼­ À¯¹æ¾Ï¿¡ °É¸° »ç¶÷ÀÌ ÀÖÀ¸¸é À¯¹æ¾ÏÀÇ ¹ß»ýÈ®·üÀÌ ¾ÆÁÖ ³ô¾ÆÁø´Ù.
  
  2.¿¡½ºÆ®·Î°Õ¿¡ Àå±âÀûÀ¸·Î ¸¹ÀÌ Æø·ÎµÇ´Â °æ¿ì£­¿¡½ºÆ®·Î°ÕÀº ¿©¼ºÈ£¸£¸óÀ¸·Î ¿©¼º¿¡¼­ Á¤»óÀûÀ¸·Î »ý¸®ÀÇ Áֱ⿡ µû¶ó Áõ°¨À» µÇÇ®ÀÌÇÑ´Ù. ÀÌ ¿¡½ºÆ®·Î°ÕÀº À¯¹æÀÇ Á¥»ùÁ¶Á÷°ú °üÁ¶Á÷ÀÇ Áõ½Ä°ú ¼ºÀå¿¡ °ü°èÇÑ´Ù. ±×¸®°í ÀÌ ¿¡½ºÆ®·Î°Õ¿¡ ¸¹ÀÌ Æø·ÎµÇ´Â »ç¶÷Àº À¯¹æ¾ÏÀÇ È®·üÀÌ ³ô´Ù. ¿ÜºÎ¿¡¼­ ¿¡½ºÆ®·Î°ÕÀÇ Á¦Á¦¸¦ Ä¡·á¸ñÀûÀ¸·Î Åõ¿©ÇÒ °æ¿ì¿¡ À¯¹æ¾ÏÀÇ ¹ß»ýÈ®·üÀº Á¤»óÀο¡¼­ º¸´Ù ÇöÀúÇϰԠ³ô¾ÆÁø´Ù. ±×¸®°í ¾ÆÀ̸¦ ³ºÁö ¾Ê°í Æò»ýÀ» »ç´Â ¿©ÀÚÀÇ °æ¿ì¿¡ ÀÓ½ÅÀ» ÇÏ°í ¾ÆÀ̸¦ ³ºÀº ¿©ÀÚ¿¡ ºñÇØ¼­ ¿¡½ºÆ®·Î°Õ¿¡ ¸¹ÀÌ Æø·Î°¡ µÇ¹Ç·Î(ÀӽŽÿ¡´Â ºñÀӽŽú¸´Ù ¿¡½ºÆ®·Î°Õ¿¡ Àû°Ô Æø·Î°¡ µÈ´Ù)À¯¹æ¾ÏÀÇ È®·üÀÌ ³ô´Ù.
  
  3.ȯ°æÀû ¿äÀΣ­Áö¹æÁú ¼·ÃëÀÇ Áõ°¡, ¼úÀÇ ¼·Ãë µîÀº À¯¹æ¾ÏÀÇ È®·üÀ» ³ôÀδÙ.
  
  À¯¹æ¾ÏÀÇ Áõ»óÀ¸·Î °¡Àå ¸¹Àº °ÍÀº ¾ÆÇÁÁö ¾ÊÀº À¯¹æÀÇ µ¢¾î¸®ÀÌ´Ù. ±×¸®°í À¯µÎ¿¡¼­ ºÐºñ¹°ÀÌ ³ª¿À°Å³ª, À¯¹æÀÇ ÇǺκ¯È­ µîÀÌ À¯¹æ¾ÏÀÇ ÈçÇÑ Áõ»óÀÌ´Ù.
  
  Ä¡·á´Â À¯¹æÀÇ ÀýÁ¦¼úÀÌ °¡Àå È¿°úÀûÀΠġ·á¹ýÀ¸·Î µÇ¾îÀÖ´Ù. ±×¸®°í À̰Ϳ¡ ´õÇÏ¿© ¹æ»ç¼± Ä¡·á³ª Ç×¾ÏÁ¦¿ä¹ýµµ È¿°ú°¡ Àִ °ÍÀ¸·Î µÇ¾îÀÖ´Ù. ¶Ç ¿¡½ºÆ®·Î°ÕÀÇ °úÀ×°ú °ü°è°¡ Àִ Á¾¾çÀÏ °æ¿ì¿¡´Â ¿¡½ºÆ®·Î°ÕÀÇ È¿°ú¸¦ Â÷´ÜÇϴ ¾à¹°µµ È¿°ú°¡ ÀÖ´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • somatic mutation theory
    ü¼¼Æ÷µ¹¿¬º¯À̼³
  • somatic mutation
    ü¼¼Æ÷µ¹¿¬º¯ÀÌ
  • clonal selection theory
    Ŭ·Ð¼±Åü³
  • convergence-projection theory
    ÆøÁÖÅõ»ç¼³, ´«¸ðÀ½Åõ»ç¼³
  • corpuscular theory
    ÀÔÀÚ¼³
  • developmental theory
    ¹ß´ÞÀÌ·Ð
  • five element theory
    ¿À¿ø¼ÒÀÌ·Ð
  • family system theory
    °¡Á·Ã¼°è·Ð
  • gate-control theory
    ¹®Á¶ÀýÀÌ·Ð
  • general system theory
    ÀϹÝü°è·Ð
  • instinct theory
    º»´ÉÀÌ·Ð
  • instructive theory
    (Ç×ü»ý»ê)Áö½Ã¼³
  • object relation theory
    ´ë»ó°ü°è·Ð
  • psychoanalytic theory
    Á¤½ÅºÐ¼®ÀÌ·Ð
  • personality theory
    ÀΰÝÀÌ·Ð
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • somatic mutation
    ü¼¼Æ÷µ¹¿¬º¯ÀÌ
  • theory
    Çм³, ¼³, ÀÌ·Ð
  • multiple causation theory
    Áúº´¹ß»ý´Ù¿äÀμ³
  • psychoanalytic theory
    Á¤½ÅºÐ¼®ÀÌ·Ð
  • mutation
    µ¹¿¬º¯ÀÌ
  • point mutation
    Á¡µ¹¿¬º¯ÀÌ
  • reverse mutation
    ¿ªµ¹¿¬º¯ÀÌ, º¹±Íµ¹¿¬º¯ÀÌ
  • mutation rate
    µ¹¿¬º¯ÀÌÀ²
  • somatic antigen
    ü¼¼Æ÷Ç׿ø, ±ÕüÇ׿ø
  • somatic disorder
    ½ÅüÀå¾Ö
  • somatic nerve
    ¸ö½Å°æ
  • somatic pain
    ¸öÅëÁõ
  • somatic sign
    ½Åü¡ÈÄ
  • cancer
    ¾Ï
  • advanced cancer
    ÁøÇà¾Ï
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • somatic mutation theory
    ü¼¼Æ÷µ¹¿¬º¯À̼³
  • somatic mutation
    ü¼¼Æ÷µ¹¿¬º¯ÀÌ
  • advanced cancer
    ÁøÇà¾Ï
  • somatic afferent
    ¸ö±¸½É½Å°æ, ¸öµé½Å°æ
  • somatic antigen
    ü¼¼Æ÷Ç׿ø, ±ÕüÇ׿ø
  • somatic motor aura
    ¸ö¿îµ¿Á¶Áü
  • breast cancer
    À¯¹æ¾Ï
  • somatic barrier
    ½ÅüÀ庮
  • cancer
    ¾Ï
  • cancer pain
    ¾ÏÅëÁõ
  • cancer registry
    ¾Ïµî·Ï»ç¾÷ºÎ
  • cauliflower cancer
    ¾ç¹èÃ߲ɾÏ
  • conjugal cancer
    ºÎºÎ¾Ï
  • corset cancer
    ÄÚ¸£¼Â¾Ï
  • duct cancer
    (¢¡duct carcinoma) °ü¾ÏÁ¾
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • antigen, somatic
    ü¼¼Æ÷Ç׿ø
  • genetics, somatic cell
    ü¼¼Æ÷À¯ÀüÇÐ
  • hallucination, somatic
    ½Åüȯ°¢(ãóô÷ü³ÊÆ)
  • frameshift mutation
    ÇØµ¶Æ² µ¹¿¬º¯ÀÌ, ÇÁ·¹ÀÓ½¬ÇÁÆ® µ¹¿¬º¯ÀÌ
  • genetic mutation
    À¯ÀüÀû µ¹¿¬º¯ÀÌ
  • genomic mutation
    À¯ÀüÀÚµ¹¿¬º¯ÀÌ
  • induced mutation
    À¯¹ßµ¹¿¬º¯ÀÌ
  • induced mutation
    À¯¹ß¼º µ¹¿¬º¯ÀÌ.
  • plaque morphology mutation
    ÇöóÅ© ÇüÅ µ¹¿¬º¯ÀÌ
  • plaque-type mutation
    ÇöóÅ©Çü µ¹¿¬º¯ÀÌ
  • point mutation
    Á¡ µ¹¿¬º¯ÀÌ
  • point mutation
    Á¡µ¹¿¬º¯ÀÌ
  • population mutation
    Áý´Ü±ºµ¹¿¬º¯ÀÌ(¡­ÔÍæÔܨì¶).
  • recessive mutation
    ¿­¼ºµ¹¿¬º¯ÀÌ(æëàõÔÍæÔܨì¶).
  • recessive mutation
    ¿­¼ºµ¹¿¬º¯ÀÌ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • somatic mutation theory
  • theory, somatic mutation
    ü¼¼Æ÷µ¹¿¬º¯À̼³ (Ç×ü´Ù¾ç¼º±â¿øÀÇ)
  • mutation, somatic
    ü¼¼Æ÷µ¹¿¬º¯ÀÌ
  • somatic mutation
    ü¼¼Æ÷µ¹¿¬º¯ÀÌ
  • antigen, somatic
    ü¼¼Æ÷Ç׿ø
  • death, somatic
    °³Ã¼»ç¸Á
  • genetics, somatic cell
    ü¼¼Æ÷À¯ÀüÇÐ
  • hallucination, somatic
    ½Åüȯ°¢(ãóô÷ü³ÊÆ)
  • paravertebral thoracic somatic nerve block
    ÈäÃßÁÖÀ§Ã¼¼º ½Å°æÂ÷´Ü, ôÃßÁÖ À§ÈäºÎü¼º ½Å°æÂ÷´Ü.
  • shock and other somatic treatment
    Ãæ°Ý ¹× ±âŸ ½Åüġ·á
  • somatic afferent
    ü¼º±¸½É½Å°æ.
  • somatic antigen
    ü¼¼Æ÷Ç׿ø
  • somatic antigen
    ±ÕüÇ׿ø(жô÷ù÷ê«).
  • somatic antigen
    ±ÕüÇ׿ø(жô÷ù÷ê«).
  • somatic barrier
    ½ÅüÀû À庮(ãóô÷îÜî¡Ûú).
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 6 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Genomic mutation
    À¯ÀüÀÚµ¹¿¬º¯ÀÌ
    [¿¾ ¿ë¾î] À¯ÀüÀÚµ¹¿¬º¯ÀÌ
  • Somatic fibers
    ¸ö½Å°æ¼¶À¯
    [¿¾ ¿ë¾î] ü½Å°æ¼¶À¯
  • Somatic neuron
    ¸ö½Å°æ¼¼Æ÷
    [¿¾ ¿ë¾î] ü¼º½Å°æ¼¼Æ÷
  • Somatic mesoderm
    ¸öÁ߹迱
    [¿¾ ¿ë¾î] üÀýÁ߹迱
  • Somatic veins
    ¸öÅëÁ¤¸Æ
    [¿¾ ¿ë¾î] üÀýÁ¤¸Æ
  • Somatic(Parietal) mesoderm
    º®ÂÊÁ߹迱
    [¿¾ ¿ë¾î] º®ÃøÁ߹迱
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • somatic antigen
    üÇ׿ø
  • somatic migration
    Á¶Á÷ÀÌÇà
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • somatic mutation theory
    ü¼¼Æ÷ º¯ÀÌÀÌ·Ð(ô÷á¬øàܨì¶×âÖå)
  • convergence theory of cancer
    "¾Ï ¼ö·Å·Ð(äßâ¥Ö°Öå),(ÔÒ) Greenstein hypothesis"
  • virus theory of cancer
    ¹ÙÀÌ·¯½º ¾Ï¹ß»ý·Ð(äßÛ¡ßæÖå)
  • somatic mutation
    ü¼¼Æ÷ º¯ÀÌ(ô÷á¬øàܨì¶)
  • somatic recombination theory
    ü¼¼Æ÷ ÀçÁ¶ÇÕ ÀÌ·Ð(ô÷á¬øàî¢ðÚùê×âÖå)
  • somatic theory
    ü¼¼Æ÷ ÀÌ·Ð(ô÷á¬øà×âÖå)
  • cancer
    ¾Ï(äß)
  • cancer biochemistry
    ¾Ï»ýÈ­ÇÐ(äßßæûùùÊ)
  • cancer gene
    ¾ÏÀ¯ÀüÀÚ(äßë¶îîí­)
  • cancer-inducing virus
    ¹ß¾Ï(Û¡äß) ¹ÙÀÌ·¯½º
  • mutation theory
    º¯ÀÌ·Ð(ܨì¶Öå)
  • somatic cell
    ü¼¼Æ÷(ô÷á¬øà)
  • somatic cell genetic engineering
    ü¼¼Æ÷ À¯Àü°øÇÐ(ô÷á¬øàë¶îîÍïùÊ)
  • somatic cell hybrid
    ü¼¼Æ÷(ô÷á¬øà) Æ¢±â
  • somatic crossing over
    ü¼¼Æ÷ ±³Â÷(ô÷á¬øàÎßó©)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • mutation
    µ¹¿¬ º¯ÀÌ
  • theory
    ¼³, ÀÌ·Ð
  • somatic
    ü(¼º)ÀÇ, ½ÅüÀÇ
  • somatic nerve
    ü(¼º)½Å°æ
  • alveolar cancer
    Æ÷»ó¾Ï
  • breast cancer
    À¯¹æ¾Ï
  • cancer
    ¾Ï
  • cancer in situ
    »óÇdz»¾Ï, ÀνÃÅõ¾Ï
  • early gastric cancer
    Á¶±âÀ§¾Ï
  • mammary cancer
    À¯¾Ï
  • ovarian cancer
    ³­¼Ò¾Ï
  • polypoid cancer
    Æú¸³¾ç¾Ï
  • primary cancer
    ¿ø¹ß¾Ï
  • radiation induced cancer
    ¹æ»ç¼±À¯¹ß¾Ï
  • skin cancer
    ÇǺξÏ
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
SDT sensory detection theory; right sacrotransverse [fetal position] [Lat. sacrodextra transversa]; sign...
AFP Alpha(¥á) Feto-Protein [HP 1826, 1858, 1859, 2265]
  ; Oncofetal Antigens
 &nbs...
ARMS adverse reaction monitoring system; amplification refractory mutation system
MF magnetic field; meat free; medium frequency; megafarad; membrane filler; merthiolate-formaldehyde [s...
TFM testicular feminization male; testicular feminization mutation; total fluid movement; transmission e...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
SMART Somatic Mutation And Recombination Test
SCC Somatic Cell Count
DFT Density Functional Theory
IRT Item Response Theory
SDT Signal Detection Theory
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • somatic mutation
    ü ¼¼Æ÷ µ¹¿¬º¯ÀÌ
  • amber mutation
    ¾Ïº£¸£ µ¹¿¬º¯ÀÌ
  • auxotrophic mutation
    ¿µ¾ç ¿ä±¸ µ¹¿¬º¯ÀÌ
  • biochemical mutation
    »ýÈ­ÇÐÀû µ¹¿¬º¯ÀÌ
  • clear plaque mutation
    Åõ¸í ÇöóÅ© µ¹¿¬º¯ÀÌ
  • cold-sensitive mutation
    ÇÑ·© ¹Î°¨¼º µ¹¿¬º¯ÀÌ
  • conditional mutation
    Á¶°ÇºÎ µ¹¿¬º¯ÀÌ
  • constitutive mutation
    ±¸¼ºÀû µ¹¿¬º¯ÀÌ
  • frameshift mutation
    °ñ°Ý ±¸Á¶ À̵¿ µ¹¿¬º¯ÀÌ
  • homoetic mutation
    È£¸Þ¿À½Ã½º µ¹¿¬º¯ÀÌ
  • missense mutation
    ¹Ì½º¼¾½º µ¹¿¬º¯ÀÌ
  • mutation
    µ¹¿¬º¯ÀÌ
    1. ÇüÅÂ, ¼º°Ý ȤÀº ¾î¶² ´Ù¸¥ Ư¡¿¡ »ý±ä º¯È­. 2. À¯ÀüÇп¡¼­´Â À¯Àü ¹°Áú¿¡ »ý±ä º¸ÅëÀº ÇϳªÀÇ À¯ÀüÀÚ¿¡ »ý±ä À¯ÀüÀÌ µÇ´Â ¿µ±¸ÀûÀÎ º¯È­. ¶ÇÇÑ °³Ã¼¿¡¼­ ³ªÅ¸³ª´Â º¯È­. ¶ÇÇÑ °íÀü À¯ÀüÇп¡¼­´Â º¯Á¾
  • mutation disturbance
    º¯¼º Àå¾Ö
  • mutation rate
    º¯ÀÌÀ², µ¹¿¬º¯ÀÌÀ²
  • ochre mutation
    ¿À¿ìÄ¿ µ¹¿¬º¯ÀÌ
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
somatic mutation theory of cancer That cancer is caused by a mutation or mutations in the body cells (as opposed to germ cells), especially nonlethal mutations associated with increased proliferation of the mutant cells.
(05 Mar 2000)
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
somatic mutation Mutation that occurs in the somatic tissues of an organism and that will not, therefore, be heritable, since it is not present in the germ line. Some neoplasia is due to somatic mutation, a more conspicuous example is the reversion of some branches of variegated shrubs to the wild type (completely green) phenotype. Somatic mutation is probably also important in generating diversity in V gene regions of immunoglobulins.
(18 Nov 1997)
general somatic afferent column In the embryo, a column of gray matter in the hindbrain and spinal cord, represented in the adult by the sensory nuclei of the trigeminal nerve and relay cells in the dorsal horn.
(05 Mar 2000)
general somatic efferent column A column of gray matter in the embryo, represented in the adult by the nuclei of the oculomotor, trochlear, abducens, and hypoglossal nerves and by motor neurons of the ventral horn of the spinal cord.
(05 Mar 2000)
psychiatric somatic therapies The biologic treatment of mental disorders (e.g., electroconvulsive therapy), in contrast with psychotherapy. (stone, american psychiatric glossary, 1988, p159)
(12 Dec 1998)
somatic 1. Pertaining to or characteristic of the soma or body.
2. Pertaining to the body wall in contrast to the viscera.
Origin: Gr. Somatikos
(18 Nov 1997)
somatic agglutinin An agglutinin that is formed as the result of stimulation by, and that reacts with, the relatively thermostable antigen(s) in the cell bodies of microorganisms.
Synonym: somatic agglutinin.
See ABO blood group.
(05 Mar 2000)
somatic antigen An antigen located in the cell wall of a bacterium in contrast to one in the flagella (flagellar antigen) or in a capsule (capsular antigen).
(05 Mar 2000)
somatic arteries Artery's that arise in the embryo from the dorsal aorta and supply the body wall; they persist almost unchanged as the posterior intercostal, subcostal, and lumbar artery's.
(05 Mar 2000)
somatic cell Usually any cell of a multicellular organism that will not contribute to the production of gametes, i.e. most cells of which an organism is made: not a germ cell. Notice, however, the alternative use in somatic mesoderm.
(18 Nov 1997)
somatic cell gene therapy The repair or replacement of a defective gene within somatic tissue.
(09 Oct 1997)
somatic cell genetics Method for identifying the chromosomal location of a particular gene without sexual crossing. Unstable heterokaryons are made between the cell of interest and another cell with identifiably different characteristics (or without the gene in question) and a series of clones isolated. By correlating retention of gene expression with the remaining chromosomes, it is possible to deduce which chromosome must carry the gene. Human mouse heterokaryons have been extensively used in this sort of work.
(18 Nov 1997)
somatic cell hybridization Production of a heterokaryon.
(05 Mar 2000)
somatic cells Cells of an animal or plant other than the reproductive cells.
(14 Nov 1997)
somatic crossing-over Crossing-over that occurs during the mitosis of somatic cells, in contrast to that which occurs in meiosis.
(05 Mar 2000)
somatic death Death of the entire body, as distinguished from local death.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • somatic
    À°Ã¼ÀÇ; ½ÅüÀÇ
  • somatic
    ½ÅüÀÇ;ü°­ÀÇ
  • cancer
    ¾Ï; ¾ÏÁ¾; ÇØ¾Ç; ÆóÇØ
  • cancer
    ¾Ï;¾ÏÁ¾;¾Ç¼ºÁ¾¾ç;(»çȸÀÇ)º´Æó;°ÔÀÚ¸®;°ÅÇØ±Ã;°ÔÀÚ¸®¿¡ ž »ç¶÷;¾Ïó·³ Ä§ÇØÇÏ´Ù;cancered (n,vt,a);¾Ï¿¡ °É¸°
  • cancer stick
    ´ã¹è(cigarette)
  • gastric cancer
    À§¾Ï
  • mutation
    º¯°æ
  • forward mutation
    ÀüÁø µ¹¿¬ º¯ÀÌ
  • frameshift mutation
    ÇÁ·¹ÀÓ½ÃÇÁÆ® µ¹¿¬ º¯ÀÌ
  • missense mutation
    ¹Ì½º¼¾½º µ¹¿¬ º¯ÀÌ
  • mutation
    º¯È­;µ¹¿¬ º¯ÀÌ;º¯Á¾;¸ðÀ½ º¯È­
  • neutral mutation
    Á߸³µ¹¿¬º¯ÀÌ
  • vowel mutation
    =UMLAUT
  • theory
    ÀÌ·Ð,-¼³,Àǰß
  • Development theory
    (»ý)(¶ó¸¶¸£Å©ÀÇ)ÁøÈ­·Ð
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á